DAVOS/LONDON (Reuters) - Danish drugmaker Novo Nordisk, the worldâ€™s top insulin supplier, expects to be ahead of the pack now nuclear sanctions are lifted in Iran, thanks to a continuous presence and a pre-emptive investment plan.
 All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.